  See all
 |
Articles: Renal/Urologic |
Prior Articles
Treating the individual: The need for a patient-focused approach to the management of renal cell carcinoma
Cancer Treatment Reviews, 10/15/09
New treatment approaches in renal cell carcinoma
Anti-Cancer Drugs, 10/15/09 Differential expression of the semaphorin 3A pathway in prostatic cancer
Histopathology, 10/15/09 Medical history, body size, and cigarette smoking in relation to fatal prostate cancer
Cancer Causes and Control, 10/14/09 High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
Annals of Oncology, 10/14/09 Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Revew Article
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09 Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort
Cancer Causes and Control, 10/13/09 Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Cancer Cell, 10/12/09 Genoproteomic Mining of Urothelial Cancer Suggests gamma-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy
American Journal of Pathology, 10/12/09 Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: The Sparc trial
Journal of Clinical Oncology, 10/08/09 A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer
Investigational New Drugs, 10/08/09
Free full text
Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases
Human Pathology, 10/08/09 AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
Oncogene, 10/08/09 NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth
Investigational New Drugs, 10/08/09 Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
British Journal of Cancer, 10/08/09 N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin
Human Pathology, 10/08/09 Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
The Journal of Nutrition, 10/08/09 Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit
European Journal of Cancer, 10/07/09 A Dosimetric Analysis Comparing Treatment of Low-Risk Prostate Cancer With TomoTherapy Versus Static Field Intensity Modulated Radiation Therapy
American Journal of Clinical Oncology, 10/07/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
